博济医药(300404.SZ)：拟减持不超过266.7万股已回购股份

Group 1 - The company, Boji Pharmaceutical (300404.SZ), announced the approval of a share repurchase plan during its 19th meeting of the fifth board of directors [1] - The repurchase plan aims to maintain the company's value and protect shareholder interests, with a maximum of 2.667 million shares to be repurchased, representing 0.69% of the total share capital [1] - The share reduction period is set to begin 15 trading days after the announcement and will last for six months, specifically from March 19, 2026, to September 18, 2026, excluding any periods prohibited by regulations [1]